Yasushi Fujio Selected Research

taurine transporter

5/2008	Taurine depletion caused by knocking out the taurine transporter gene leads to cardiomyopathy with cardiac atrophy.
3/2006	Myogenic differentiation induces taurine transporter in association with taurine-mediated cytoprotection in skeletal muscles.
1/2006	Myogenic induction of taurine transporter prevents dexamethasone-induced muscle atrophy.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Yasushi Fujio Research Topics

Disease

11	Heart Failure 04/2022 - 09/2004
9	Inflammation (Inflammations) 01/2020 - 08/2004
9	Ischemia 01/2017 - 04/2004
8	Neoplasms (Cancer) 01/2021 - 03/2002
7	Fibrosis (Cirrhosis) 01/2021 - 02/2010
7	Cardiomegaly (Heart Hypertrophy) 01/2019 - 07/2002
6	Hypertrophy 01/2021 - 07/2002
5	Reperfusion Injury 01/2018 - 02/2005
4	Cardiovascular Diseases (Cardiovascular Disease) 01/2020 - 03/2008
4	Infarction (Infarctions) 01/2019 - 02/2010
4	Myocardial Infarction 01/2019 - 02/2010
4	Atherosclerosis 01/2012 - 09/2003
4	Cardiomyopathies (Cardiomyopathy) 07/2008 - 07/2002
4	Diabetic Retinopathy (Retinopathy, Diabetic) 03/2008 - 02/2003
3	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 01/2020 - 09/2013
2	Chronic Renal Insufficiency 01/2022 - 01/2021
2	Hypoxia (Hypoxemia) 01/2022 - 07/2007
2	Body Weight (Weight, Body) 01/2022 - 08/2010
2	ST Elevation Myocardial Infarction 01/2018 - 09/2016
2	Myocarditis (Carditis) 01/2016 - 09/2011
2	Dilated Cardiomyopathy (Cardiomyopathy, Congestive) 08/2010 - 09/2004
2	Pulmonary Arterial Hypertension 06/2009 - 03/2007
2	Cardiotoxicity 01/2009 - 07/2008
2	Atrophy 05/2008 - 03/2006
2	Muscular Atrophy (Muscle Atrophy) 03/2006 - 01/2006
2	Anaplastic Large-Cell Lymphoma (Ki 1 Lymphoma) 07/2004 - 06/2004
1	Type 2 Diabetes Mellitus (MODY) 04/2022
1	Diabetic Nephropathies (Diabetic Nephropathy) 01/2022
1	Infections 01/2022
1	Ureteral Obstruction 01/2021
1	Cardiac Arrhythmias (Arrythmia) 11/2020
1	Irritable Bowel Syndrome (Syndrome, Irritable Bowel) 11/2020
1	Constipation 11/2020
1	Gastrointestinal Diseases (Functional Gastrointestinal Disorders) 11/2020
1	Adenocarcinoma of Lung 01/2020
1	Dyspnea (Shortness of Breath) 01/2019
1	Polycystic Kidney Diseases (Polycystic Kidney Disease) 01/2019

Drug/Important Bio-Agent (IBA)

9	CytokinesIBA 01/2020 - 08/2003
7	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 01/2022 - 09/2003
7	Taurine FDA Link 08/2010 - 04/2004
6	Interleukin-11 (Interleukin 11)IBA 01/2018 - 05/2007
5	Interleukin-6 (Interleukin 6)IBA 01/2017 - 09/2004
4	Proteins (Proteins, Gene)FDA Link 01/2022 - 03/2011
4	STAT3 Transcription Factor (Signal Transducer and Activator of Transcription 3)IBA 01/2017 - 07/2004
4	Doxorubicin (Adriamycin)FDA LinkGeneric 01/2009 - 03/2002
3	Biomarkers (Surrogate Marker)IBA 01/2022 - 02/2016
3	ErbB Receptors (EGF Receptor)IBA 01/2020 - 07/2007
3	LigandsIBA 01/2019 - 08/2004
3	Phosphotransferases (Kinase)IBA 01/2018 - 05/2008
3	Pharmaceutical PreparationsIBA 05/2013 - 03/2002
3	Endothelin-1 (Endothelin 1)IBA 06/2009 - 03/2007
3	taurine transporterIBA 05/2008 - 01/2006
2	Blood Glucose (Blood Sugar)IBA 01/2022 - 03/2008
2	Tyrosine Kinase InhibitorsIBA 01/2021 - 12/2018
2	Transcription Factors (Transcription Factor)IBA 01/2021 - 01/2021
2	Erlotinib Hydrochloride (CP 358,774)FDA Link 01/2020 - 12/2018
2	Adrenergic Receptors (Adrenergic Receptor)IBA 01/2019 - 10/2005
2	Adrenergic Agents (Adrenergic Drugs)IBA 01/2019 - 02/2008
2	Calcium-Calmodulin-Dependent Protein Kinase Type 2IBA 01/2018 - 03/2017
2	InterleukinsIBA 01/2018 - 09/2011
2	Calmodulin (Calcium-Dependent Activator Protein)IBA 01/2018 - 04/2013
2	CalciumIBA 01/2017 - 04/2013
2	OsteopontinIBA 04/2013 - 10/2011
2	Glycoproteins (Glycoprotein)IBA 01/2011 - 02/2010
2	Bosentan (Tracleer)FDA Link 06/2009 - 03/2007
2	Endothelins (Endothelin)IBA 06/2009 - 07/2002
2	Amino Acids FDA Link 05/2008 - 10/2004
2	Messenger RNA (mRNA)IBA 07/2007 - 10/2005
2	Dexamethasone (Maxidex)FDA LinkGeneric 03/2006 - 01/2006
2	Biological ProductsIBA 03/2006 - 10/2005
2	Platelet Activating FactorIBA 07/2005 - 08/2004
2	Cytochromes c (Cytochrome c)IBA 10/2004 - 04/2004
2	Caspase 9IBA 10/2004 - 04/2004
2	Anaplastic Lymphoma KinaseIBA 07/2004 - 06/2004
1	ipragliflozinIBA 04/2022
1	Disinfectants (Biocides)IBA 01/2022
1	Tumor Suppressor Protein p53IBA 01/2022
1	triciribineIBA 01/2021
1	Tretinoin (Retinoic Acid)FDA LinkGeneric 01/2021
1	IGF Type 1 Receptor (IGF 1 Receptor)IBA 01/2021
1	WortmanninIBA 01/2021
1	Insulin-Like Growth Factor I (IGF-1)IBA 01/2021
1	Vascular Endothelial Growth Factor Receptors (VEGF Receptors)IBA 01/2021
1	SR 3335IBA 01/2021
1	NVP-AEW541IBA 01/2021
1	Phosphatidylinositols (Phosphatidylinositol)IBA 01/2021
1	Cisapride (Propulsid)FDA Link 11/2020
1	5-HT4 Serotonin ReceptorsIBA 11/2020
1	tegaserod (Zelnorm)FDA Link 11/2020
1	Progesterone Receptors (Progesterone Receptor)IBA 01/2020
1	CateninsIBA 01/2020
1	Tamoxifen FDA LinkGeneric 01/2019
1	Cyclic AMP-Dependent Protein Kinases (cAMP-Dependent Protein Kinase)IBA 01/2019
1	Prokaryotic Initiation Factor-3IBA 12/2018

Therapy/Procedure

11	Therapeutics 01/2021 - 12/2010
2	Renal Dialysis (Hemodialysis) 01/2019 - 03/2008
2	Drug Therapy (Chemotherapy) 12/2018 - 05/2013
2	Precision Medicine 12/2010 - 11/2006
1	Kidney Transplantation 01/2019
1	Intraperitoneal Injections 01/2019